SAIPARENT Share Price | Sai Parenterals Ltd Stock Analysis & Recommendation

Q: Why is Sai Parenterals Ltd falling/rising?

As of 05-Sep, Sai Parenterals Ltd's stock price is currently at 517.95, reflecting a slight decrease of 0.15, or 0.03%. The stock has been experiencing a downward trend, as indicated by its performance over various periods. In the last week, the stock has fallen by 0.47%, while over the past month, it has decreased by 2.50%. Additionally, the stock is trading below its moving averages across multiple time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which suggests a bearish trend.Despite a recent outperformance against its sector by 0.48% and a consecutive gain over the last two days with a total return of 0.32%, the overall sentiment appears negative. This is further supported by a significant drop in investor participation, with delivery volume on September 3 falling by 46.48% compared to the 5-day average. The liquidity of the stock remains adequate for trading, but the combination of declining performance metrics and reduced investor engagement indicates that the stock is currently facing downward pressure.

Q: What does Sai Parenteral's do?

Overview:Sai Parenterals Ltd operates in the Pharmaceuticals & Biotechnology industry and is categorized as a Small Cap company.History:Sai Parenterals Ltd was originally incorporated as 'Sai Parenteral's Private Limited' on January 12, 2001. The company transitioned to a Public Limited Company and changed its name to 'Sai Parenteral's Limited' on January 17, 2022. The most recent quarterly results reported net sales and net profit for June 2026.Financial Snapshot:Net Sales: 179 Cr (Quarterly Results - Jun 2026) Net Profit: 8 Cr (Quarterly Results - Jun 2026) Market Cap: INR 2,284 Cr (Small Cap)Key Metrics:P/E: 145.00 Industry P/E: 37 Dividend Yield: 0.00% Debt Equity: -0.17 Return on Equity: 2.91% Price to Book: 4.68 Contact Details:Details: No Company Details Available Registrar Address: Not available.

Q: Who are the peers of the Sai Parenteral's?

Peers: Sai Parenteral's has the following peers: Dishman Carbogen, Hikal, Fredun Pharma, Panacea Biotec, Indoco Remedies, Venus Remedies, Windlas Biotech, Hester Bios, Beta Drugs Ltd, Sakar Healthcare.Quality Snapshot: Below Average management risk is observed at Dishman Carbogen and Panacea Biotec, while Average management risk is found at Hikal, Fredun Pharma, Indoco Remedies, Venus Remedies, Windlas Biotech, Hester Bios, Beta Drugs Ltd, Sakar Healthcare, and the rest. Growth is Excellent at Fredun Pharma, Good at Dishman Carbogen and Venus Remedies, while Below Average growth is noted at Hikal, Panacea Biotec, Indoco Remedies, Windlas Biotech, Hester Bios, Sakar Healthcare, and the rest. Capital Structure is Excellent at Venus Remedies and Beta Drugs Ltd, while Below Average is seen at Dishman Carbogen, Hikal, Fredun Pharma, Panacea Biotec, Indoco Remedies, Hester Bios, and the rest.Return Snapshot: Fredun Pharma has the highest 1-year return at 279.00%, while Dishman Carbogen has the lowest at -32.34%. Sai Parenteral's does not have a 1-year return available for comparison. Additionally, Beta Drugs Ltd and Sakar Healthcare have a six-month return of 0.00%.

Technical Trend Update: Sai Parenteral's witnessed a change in Technical Grade on 21 Sep 2026. Click here to discover latest technical change!

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

13.86 k (-41.56%) Volume

Shareholding (Jun 2026)

FII

4.03%

Held by 7 FIIs

DII

8.52%

Held by 3 DIIs

Promoter

51.16%

Which are the latest news on Sai Parenteral's?

22-Sep-2026

When is the next results date for Sai Parenterals Ltd?

Why is Sai Parenterals Ltd falling/rising?

06-Sep-2026

As of 05-Sep, Sai Parenterals Ltd's stock price is 517.95, showing a slight decrease and a bearish trend with declines over the past week and month. Despite a recent outperformance against its sector, overall sentiment remains negative due to reduced investor participation and trading below moving averages.

View full answer

What does Sai Parenteral's do?

01-Sep-2026

Sai Parenterals Ltd is a small-cap company in the Pharmaceuticals & Biotechnology industry, incorporated in 2001 and transitioned to a public company in 2022. As of June 2026, it reported net sales of ₹179 crore and a net profit of ₹8 crore, with a market cap of ₹2,284 crore.

View full answer

Who are the peers of the Sai Parenteral's?

01-Sep-2026

Sai Parenteral's peers include Dishman Carbogen, Hikal, Fredun Pharma, and others, with varying management risks and growth rates. Fredun Pharma leads in 1-year returns at 279%, while Dishman Carbogen has the lowest at -32.34%.

View full answer

How big is Sai Parenteral's?

01-Sep-2026

As of 31st August, Sai Parenterals Ltd has a market capitalization of 2,284.00 Cr, with net sales of 506.14 Cr and a net profit of 15.84 Cr reported in the latest four quarters. The company has shareholder's funds of 490.77 Cr and total assets of 1,416.11 Cr for the annual period ending in March 2026.

View full answer

When is the next results date for Sai Parenterals Ltd?

05-Aug-2026

The next results date for Sai Parenterals Ltd is 11 August 2026.

View full answer

Compare Sai Parenteral's with Similar Stocks

Beta Drugs Ltd Panacea Biotec Windlas Biotech

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 2,244 Cr (Small Cap)

P/E

143.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.17

Return on Equity

2.91%

Price to Book

4.60

Revenue and Profits:

Net Sales:

179 Cr

(Quarterly Results - Jun 2026)

Net Profit:

8 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-13.72%

6 Months

0.0%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Sai Parenteral's for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

When is the next results date for Sai Parenterals Ltd?

The next results date for Sai Parenterals Ltd is scheduled for 11 August 2026....

Read full news article

Announcements

Shareholder Meeting / Postal Ballot-Scrutinizers Report

10-Sep-2026 | Source : BSE

Scrutinizers Report and Voting Results for the 25th Annual General Meeting held on 10th September 2026.

Shareholder Meeting / Postal Ballot-Outcome of AGM

10-Sep-2026 | Source : BSE

Outcome of 25th Annual General Meeting held on 10th September 2026.

Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

25-Aug-2026 | Source : BSE

Announcement under Regulation 30 (LODR)

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

1.93

Debt to EBITDA (avg)

8.61

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.46

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

12.56%

ROCE (avg)

5.37%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

143

Industry P/E

Price to Book Value

4.60

EV to EBIT

99.49

EV to EBITDA

56.17

EV to Capital Employed

5.34

EV to Sales

5.71

PEG Ratio

Dividend Yield

ROCE (Latest)

5.37%

ROE (Latest)

2.91%

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

No Signal

Bollinger Bands

Sideways

KST

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Jun 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (0.98%)

FIIs

Held by 7 FIIs (4.03%)

Promoter with highest holding

Vijitha Gorrepati (28.91%)

Highest Public shareholder

Bhaskara Rao Bollineni (4.56%)

Individual Investors Holdings

25.33%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -7.06% vs 47.58% in Mar 2026",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -10.75% vs 2,663.89% in Mar 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "52.78",
          "val2": "56.79",
          "chgp": "-7.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.35",
          "val2": "13.22",
          "chgp": "0.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.57",
          "val2": "3.42",
          "chgp": "4.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "8.88",
          "val2": "9.95",
          "chgp": "-10.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.29%",
          "val2": "23.28%",
          "chgp": "2.01%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "86.92",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "16.17",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "4.63",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7.77",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.60%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Jun'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "265.59",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "39.69",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "13.99",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "15.69",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.94%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 133.58% vs 6.08% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -1.18% vs 71.38% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "381.00",
          "val2": "163.11",
          "chgp": "133.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "38.70",
          "val2": "39.38",
          "chgp": "-1.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "18.44",
          "val2": "11.91",
          "chgp": "54.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "14.26",
          "val2": "14.43",
          "chgp": "-1.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.16%",
          "val2": "24.14%",
          "chgp": "-13.98%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ

Jun'26

Mar'26

Change(%)

Net Sales

52.78

56.79

-7.06%

Operating Profit (PBDIT) excl Other Income

13.35

13.22

0.98%

Interest

3.57

3.42

4.39%

Exceptional Items

0.00

Standalone Net Profit

8.88

9.95

-10.75%

Operating Profit Margin (Excl OI)

25.29%

23.28%

2.01%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2026 is -7.06% vs 47.58% in Mar 2026

Standalone Net Profit

QoQ Growth in quarter ended Jun 2026 is -10.75% vs 2,663.89% in Mar 2026

All Quarterly Results

Half Yearly Results Snapshot (Consolidated) - Sep'25

Sep'25

Change(%)

Net Sales

86.92

Operating Profit (PBDIT) excl Other Income

16.17

Interest

4.63

Exceptional Items

0.00

Consolidate Net Profit

7.77

Operating Profit Margin (Excl OI)

18.60%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Consolidated Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Nine Monthly Results Snapshot (Consolidated) - Jun'26

Jun'26

Change(%)

Net Sales

265.59

Operating Profit (PBDIT) excl Other Income

39.69

Interest

13.99

Exceptional Items

0.00

Consolidate Net Profit

15.69

Operating Profit Margin (Excl OI)

14.94%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Consolidated Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Consolidated) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

381.00

163.11

133.58%

Operating Profit (PBDIT) excl Other Income

38.70

39.38

-1.73%

Interest

18.44

11.91

54.83%

Exceptional Items

0.00

Consolidate Net Profit

14.26

14.43

-1.18%

Operating Profit Margin (Excl OI)

10.16%

24.14%

-13.98%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is 133.58% vs 6.08% in Mar 2025

Consolidated Net Profit

YoY Growth in year ended Mar 2026 is -1.18% vs 71.38% in Mar 2025

All Annual Results

Company CV

About Sai Parenterals Ltd

Sai Parenterals Ltd

Small Cap

Pharmaceuticals & Biotechnology

Sai Parenteral's Limited was originally incorporated as `Sai Parenteral's Private Limited', a Private Limited Company on January 12, 2001, with the Registrar of Companies, at Hyderabad. Thereafter, Company was converted into a Public Limited Company and the name of Company was changed to `Sai Parenteral's Limited' w.e.f January 17, 2022.

Company Coordinates

No Company Details Available